August 30, 2016 2:21 AM ET


Company Overview of OncoPep, Inc.

Executive Profile

Kenneth C. Anderson M.D.

Scientific Founder, Director and Member of Scientific Advisory Board, OncoPep, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 12 different industries.

See Board Relationships


Dr. Kenneth C. Anderson, also known as Ken, M.D. has been the Chief of Division of Hematologic Neoplasia at the Dana-Farber Cancer Institute since 2002. Dr. Anderson has been a Councilor at American Society Of Hematology since January 2010. He is Scientific Founder of Acetylon Pharmaceuticals, Inc. and OncoPep, Inc. He is the Founder of C4 Therapeutics, Inc. He has been an Attending Physician at the Bone Marrow Transplantation Service at Brigham and Women's Hospital ...

Corporate Headquarters

520 Boston Street
North Andover, Massachusetts 01845

United States

Phone: 978-837-1129
Fax: --

Board Members Memberships

Scientific Founder, Director and Member of the Scientific Advisory Board
Scientific Founder, Director and Member of Scientific Advisory Board


MA 2000
Harvard University
BA 1973
Boston University
MD 1977
Johns Hopkins School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OncoPep, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at